To include your compound in the COVID-19 Resource Center, submit it here.

Cidecin daptomycin: Completed Phase III trial enrollment

CBST expects to complete enrollment of a U.S. Phase III trial for the same indication

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE